Major Medicare Update: Weight loss drug coverage begins July 1, 2026
For years, one of the most frustrating phone calls I’ve had to take goes like this: “Cindy, can I get my Medicare plan to cover Wegovy or Zepbound for weight loss?”
Up until now, the answer has always been a flat no. By law, Medicare has been strictly banned from covering popular GLP-1 medications if they are prescribed solely for weight loss.
But beginning July 1, 2026, that is officially changing for some beneficiaries.
The Centers for Medicare & Medicaid Services (CMS) is launching a brand-new, temporary pilot called the Medicare GLP-1 Bridge Program. It is scheduled to run through December 31, 2027, and it is designed to finally give qualifying seniors access to these medications.
Here is exactly what you need to know about how it works, who qualifies, and — most importantly — the hidden catch you need to watch out for.
Quick Facts at a Glance
How the GLP-1 Bridge Program Works
The most important thing to understand is that this program is completely separate from your Medicare Part D prescription drug plan.
You will not see these medications added to your normal plan formulary, and your private insurance carrier will not be handling the claims. Instead, the federal government (CMS) is running this program directly through a central processor.
The cost: Pharmacies will collect a flat $50 copay for approved medications through this program.
The process: Your doctor must submit a specialized prior authorization request directly to CMS. If approved, the pharmacy bills the Bridge Program directly — not your Part D card.
The processor: CMS is using Humana (the current LI NET administrator) as the central processor for prior authorization, claims, and pharmacy payments.
Which Medications Are Covered?
Three GLP-1 medications are covered when prescribed to reduce excess body weight and maintain weight reduction:
Already taking a GLP-1 for diabetes or heart disease? If you are currently taking Ozempic, Wegovy, or another GLP-1 for Type 2 diabetes or a covered cardiovascular condition, nothing changes. Your current Medicare Advantage or Part D plan will continue to cover your medication just like it does today.
Do You Qualify?
Eligibility is not automatic. Your doctor must submit a prior authorization request attesting that you meet specific clinical criteria. Generally, CMS requires:
You must be enrolled in a standalone Part D prescription drug plan (PDP) or a Medicare Advantage plan that includes drug coverage (MA-PD). Beneficiaries in Special Needs Plans (SNPs) and employer group waiver plans (EGWPs) are also eligible.
Important timing detail: You must meet the clinical criteria at the time you first started GLP-1 therapy — not necessarily at the time of the prior authorization request. If you started taking a GLP-1 in 2024 with a BMI of 37 and your BMI has dropped to 34 by the time you apply in July 2026, you still qualify based on your original BMI.
The Catch: Watch Your Out-of-Pocket Max
This is the detail most people will miss:
Because this program operates entirely outside of standard Medicare Part D, the money you spend on copays through the Bridge Program will NOT count toward your annual Part D maximum out-of-pocket drug costs (TrOOP).
The $50 monthly copay stays the same regardless of what phase of the Part D benefit you are in. Low-income subsidies do not apply to any portion of the copay either.
If you are someone who tracks your annual drug spending closely to stay below coverage thresholds, you need to keep this separate ledger in mind. The Bridge Program and your Part D plan are two completely separate financial tracks.
The $50 copay does not count toward your Part D out-of-pocket maximum. Keep a separate record.
What Does Not Change
If your doctor prescribes a GLP-1 medication for a use that is already coverable under standard Medicare Part D — for example, Wegovy for cardiovascular risk reduction in adults with established heart disease, or Zepbound for obstructive sleep apnea — your Part D plan continues to handle that coverage. The Bridge Program is only for weight loss prescriptions that Medicare has historically been banned from covering.
Your existing Part D coverage, formulary, and appeal rights remain unchanged. CMS has stated it will monitor Part D plans to ensure they do not shift coverage decisions from the Part D benefit to the Bridge Program.
Frequently Asked Questions
Do I need to do anything to enroll in the Bridge Program?
You do not enroll separately. If you meet the clinical criteria and your doctor submits a prior authorization request to CMS, you can access covered medications at participating pharmacies. Your pharmacy will submit the claim to the Bridge Program’s central processor, not your Part D plan.
Can my pharmacy participate?
Pharmacies do not need to opt in. CMS has established a specific BIN and PCN (028918 / MEDDGLP1BR) for Bridge Program claims. Your pharmacist will know where to send the claim.
What if my doctor is not enrolled in Medicare?
Your doctor does not need to be enrolled in Medicare to write the prescription or submit the prior authorization request. However, the provider must not be on CMS’s Preclusion List.
I started a GLP-1 before July 2026. Can I still qualify?
Yes. The clinical criteria are based on your status when you first initiated GLP-1 therapy, not when you apply. If you met the BMI and health criteria at the time you started, you can qualify even if your numbers have changed since then.
What happens after December 2027?
The Bridge Program is designed as a temporary pilot. CMS originally planned a longer-term program called the BALANCE Model. The Bridge runs through December 31, 2027, while CMS collects data and plans next steps. What happens after that date has not been finalized.
Can I use manufacturer coupons or discount programs with the Bridge Program?
No. CMS has stated that coupons and discount programs may not be applied to Bridge Program claims.
Next Steps
Medicare rules are constantly evolving, and keeping up with them can give anyone a massive headache.
If you have been struggling to afford your weight loss medications, the very first step is to schedule an appointment with your doctor to see if you meet the clinical criteria for the CMS application.
If you want to look at how this new pilot interacts with your current coverage, or if you simply want a clear, pressure-free look at your overall Medicare options, I am here to help.
As an independent advisor, my goal is to give you honest answers in plain English.
Have Questions About the GLP-1 Bridge Program?
Book a free, 30-minute Medicare review and we’ll walk through how this new program interacts with your current coverage.
Schedule Your Free Medicare ReviewNo pressure. No obligation. Just clarity from an independent Medicare advisor.
Source: Centers for Medicare & Medicaid Services (CMS). Medicare GLP-1 Bridge. Page last modified May 6, 2026. All clinical criteria and program details referenced in this post are drawn from the official CMS FAQ page.
Eligry LLC is a licensed independent agent. Not affiliated with or endorsed by the U.S. government or the federal Medicare program. NPN 21601670.